Form 4: Labcorp CFO Exercises RSUs, Sells Shares for Tax
Insider Transaction Report
Labcorp's Chief Financial Officer, Julia Aijun Wang, exercised 860 Restricted Stock Units and sold 245 shares to cover tax obligations.
Summary
- Julia Aijun Wang, Chief Financial Officer and Executive Vice President of Labcorp Holdings Inc., reported transactions involving company stock.
- On February 11, 2026, 860 Restricted Stock Units (RSUs) vested and were converted into Common Stock.
- Concurrently, 245 shares of Common Stock were disposed of at a price of $289.89 per share to satisfy tax withholding obligations.
- Following these transactions, Ms. Wang directly beneficially owns 1,817.239 shares of Common Stock and 4,964 Restricted Stock Units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, reflecting standard executive compensation practices rather than a change in company performance or outlook.
Industry Context
StockSavvy.ai notes that RSU exercises and tax-related sales are common executive compensation events and do not typically signal a change in company fundamentals or broader industry trends. This transaction is a routine occurrence for an executive receiving equity compensation.
Stakeholder Impact
- Minimal direct impact on shareholders, as this is a routine executive compensation transaction.
- No direct impact on employees, customers, suppliers, or creditors from this specific filing.
Next Steps
- Future vesting of remaining Restricted Stock Units in equal annual installments, as part of the original grant.
Key Dates
| Date | Description |
|---|---|
| 02/11/2026 | Date of RSU exercise and common stock disposition. |
| 02/11/2026 | First annual installment vesting date for the Restricted Stock Units. |
| 02/13/2026 | Date the Form 4 was signed and filed. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event involving the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax liabilities. Such transactions are common and do not typically indicate a change in the company's operational performance or strategic direction, thus not warranting a change in investment recommendation based solely on this filing.
Keywords
Labcorp Holdings Inc., LH, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Sale, CFO, Executive Compensation, Julia Aijun Wang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.